Suggestions
John Gordon
Professor Emeritus; co-Founder Celentyx Ltd; B-cell aficionado
John Gordon is a prominent figure in the field of immunology, currently serving as Professor Emeritus at the University of Birmingham. He has made significant contributions to cellular immunology and is recognized as an authority on immune cell biology and immune-mediated diseases.
Academic and Professional Background
- Position: Professor Emeritus of Cellular Immunology.
- Former Role: Head of the College of Medical and Dental Sciences Graduate School at the University of Birmingham.
- Co-founder and Chief Scientific Officer (CSO): Celentyx Ltd, a company focused on advancing immunotherapy and cancer research.
- Visiting Professor: Raine Visiting Professor at the University of Western Australia.
Research Contributions
John Gordon has been influential in pioneering the field of Neuro-Immuno-Pharmacology and has a notable track record in translational medicine. His work is highly cited, underscoring his impact on the scientific community. He has been involved in various research areas including:
- Cell Biology
- Hematology
- Immunology
- Pharmacology
Recent Activities
Gordon continues to engage with current research topics, particularly in cancer immunology, as evidenced by his recent posts on LinkedIn, where he discusses advancements in immunotherapy and its applications in both canine and human contexts.123
His expertise and ongoing contributions make him a key figure in advancing our understanding of immune responses and their implications for medical science.
